Latest AI and machine learning research in psychiatry for healthcare professionals.
Alcohol Use Disorder (AUD) is a chronic, relapsing condition, and identifying periods of elevated lapse risk remains a major challenge in supporting recovery. An automated recovery monitoring and support system using personal sensing and machine learning may help detect when individuals are at heightened risk. Cellular communication sensing may be a promising approach for passively capturing risk-...
Early identification of individuals at risk of developing psychosis enables timely intervention and better clinical outcomes. Current approach relies on clinical assessments, such as the Comprehensive Assessment for At‑Risk Mental States (CAARMS), which provides an Ultra‑High‑Risk (UHR) classification but have limited predictive precision. Artificial intelligence (AI) models integrating neuroimagi...
Dietary therapy is central to irritable bowel syndrome (IBS) management, yet the long-term durability of the low-FODMAP diet (LFD), and of microbiome-...
BACKGROUND: Irritable bowel syndrome (IBS) is one of the most common disorders of gut-brain interaction in gastroenterology clinics worldwide, becomin...
Generative artificial intelligence (AI) is reshaping creative industries, raising questions about how people evaluate AI-generated work. Building on e...
PURPOSE: This study examines the impact of Artificial Intelligence (AI)-enhanced instructional tools on science learning, engagement, and social inter...
Objective, scalable assessment of executive function in Attention-Deficit/Hyperactivity Disorder (ADHD) is limited by subjective rating scales and sin...
BACKGROUND: Electrographic flow (EGF) mapping is an FDA 510(k)-cleared method for visualizing atrial activation wavefronts in atrial fibrillation (AF)...
INTRODUCTION: Standardized patients (SPs) are widely used in pharmacy education for communication skills training, but high resource demands limit pra...
Major depressive disorder (MDD) is a prevalent mental health condition with profound consequences on daily functioning and quality of life. Existi...
G protein-coupled receptors (GPCRs) are major therapeutic targets for central nervous system disorders, with more than 500 approved drugs targeting th...
Artificial intelligence (AI) has entered psychiatry at scale, yet its clinical impact remains constrained by a sizable gap between technical validatio...
BACKGROUND: Using speech as objective markers for major depressive disorder (MDD) has shown promise, yet their generalizability across clinical settin...
Over 40% of Obsessive-Compulsive Disorder (OCD) patients do not respond to common treatments. This study was a secondary analysis of data from a rando...
Hikikomori, or prolonged social withdrawal, is an issue of global relevance. The HRI-15 is a brief tool for its assessment. This study enhances its ut...
Accurate psychological evaluation is crucial for early detection, intervention and evaluation of mental health disorders. The validity and reliability...
BACKGROUND: Mental health apps are frequently used as platforms for delivering digital health interventions to young people. New technology such as ge...
Early identification of Treatment-resistant schizophrenia (TRS) remains a challenge. Metabolomics offers a promising strategy for identifying biomarke...
OBJECTIVE: Chronic schizophrenia patients in psychiatric hospitals often have prolonged stays, high insurance resource consumption, and low efficiency...
Regular physical activity (PA) remains challenging for many people with high cardiovascular risk and established cardiovascular disease (CVD). We aime...